IGMS IGM Biosciences | $2.09 -66.3% | 1/10/2025 | Downgraded by | Guggenheim | Analyst M. Schmidt | Buy -> Neutral | | High | View details for Guggenheim rating of IGM Biosciences (NASDAQ:IGMS) on 1/10/2025 |
SWTX SpringWorks Therapeutics | $43.00 +6.2% | 1/8/2025 | Target Lowered by | Guggenheim | - | Buy -> Buy | $80.00 -> $78.00 | Medium | View details for Guggenheim rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/8/2025 |
WMG Warner Music Group | $29.34 +0.1% | 1/8/2025 | Target Lowered by | Guggenheim | - | Buy -> Buy | $44.00 -> $40.00 | Medium | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 1/8/2025 |
PWR Quanta Services | $314.03 +0.6% | 1/8/2025 | Initiated by | Guggenheim | Analyst J. Osha | Neutral | | High | View details for Guggenheim rating of Quanta Services (NYSE:PWR) on 1/8/2025 |
PRIM Primoris Services | $77.63 -1.6% | 1/8/2025 | Initiated by | Guggenheim | Analyst J. Osha | Buy | $102.00 | Medium | View details for Guggenheim rating of Primoris Services (NASDAQ:PRIM) on 1/8/2025 |
MTZ MasTec | $144.72 -1.3% | 1/8/2025 | Initiated by | Guggenheim | Analyst J. Osha | Buy | $195.00 | Low | View details for Guggenheim rating of MasTec (NYSE:MTZ) on 1/8/2025 |
|
EXEL Exelixis | $36.02 +4.4% | 1/7/2025 | Target Raised by | Guggenheim | - | Buy -> Buy | $33.00 -> $42.00 | Low | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 1/7/2025 |
WDAY Workday | $249.71 -2.0% | 1/6/2025 | Upgraded by | Guggenheim | Analyst J. Difucci | Sell -> Neutral | | N/A | View details for Guggenheim rating of Workday (NASDAQ:WDAY) on 1/6/2025 |
PANW Palo Alto Networks | $173.42 +0.3% | 1/6/2025 | Downgraded by | Guggenheim | Analyst J. Difucci | Neutral -> Sell | $130.00 -> $130.00 | N/A | View details for Guggenheim rating of Palo Alto Networks (NASDAQ:PANW) on 1/6/2025 |
MDB MongoDB | $245.22 -1.4% | 1/6/2025 | Upgraded by | Guggenheim | Analyst H. Ma | Neutral -> Buy | $300.00 -> $300.00 | N/A | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 1/6/2025 |
CRM Salesforce | $317.83 -2.8% | 1/6/2025 | Downgraded by | Guggenheim | Analyst J. Difucci | Neutral -> Sell | $247.00 -> $247.00 | N/A | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 1/6/2025 |
DT Dynatrace | $50.64 -3.0% | 1/6/2025 | Downgraded by | Guggenheim | Analyst J. Difucci | Buy -> Neutral | | N/A | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 1/6/2025 |
SRZN Surrozen | $11.15 -13.0% | 1/3/2025 | Upgraded by | Guggenheim | Analyst Y. Suneja | Neutral -> Buy | $45.00 -> $45.00 | N/A | View details for Guggenheim rating of Surrozen (NASDAQ:SRZN) on 1/3/2025 |
ACAD ACADIA Pharmaceuticals | $17.26 -1.9% | 1/3/2025 | Downgraded by | Guggenheim | Analyst Y. Suneja | Buy -> Neutral | $23.00 -> $20.00 | N/A | View details for Guggenheim rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 1/3/2025 |
SARTF Sartorius Aktiengesellschaft | $188.30 +1.7% | 12/19/2024 | Upgraded by | Guggenheim | Analyst S. Nambi | Strong-Buy | | N/A | View details for Guggenheim rating of Sartorius Aktiengesellschaft (OTCMKTS:SARTF) on 12/19/2024 |
RDDT Reddit | $167.48 -2.6% | 12/20/2024 | Initiated by | Guggenheim | Analyst M. Morris | Buy | $210.00 | N/A | View details for Guggenheim rating of Reddit (NYSE:RDDT) on 12/20/2024 |
KR Kroger | $59.24 +0.6% | 12/19/2024 | Initiated by | Guggenheim | - | Buy | $68.00 | N/A | View details for Guggenheim rating of Kroger (NYSE:KR) on 12/19/2024 |
BRKR Bruker | $60.78 -0.3% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $72.00 | N/A | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 12/19/2024 |
CYRX Cryoport | $8.51 -3.5% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $11.00 | N/A | View details for Guggenheim rating of Cryoport (NASDAQ:CYRX) on 12/19/2024 |
DHR Danaher | $235.08 -1.3% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $275.00 | N/A | View details for Guggenheim rating of Danaher (NYSE:DHR) on 12/19/2024 |
MRVI Maravai LifeSciences | $4.85 -20.9% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Neutral | | N/A | View details for Guggenheim rating of Maravai LifeSciences (NASDAQ:MRVI) on 12/19/2024 |
NEOG Neogen | $12.36 -5.4% | 12/19/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $15.00 | N/A | View details for Guggenheim rating of Neogen (NASDAQ:NEOG) on 12/19/2024 |
KROS Keros Therapeutics | $14.56 -2.2% | 12/16/2024 | Downgraded by | Guggenheim | Analyst V. Divan | Buy -> Neutral | | N/A | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 12/16/2024 |
RH RH | $414.75 +1.6% | 12/13/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $425.00 -> $550.00 | N/A | View details for Guggenheim rating of RH (NYSE:RH) on 12/13/2024 |
APGE Apogee Therapeutics | $41.05 -16.6% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 12/12/2024 |
ARVN Arvinas | $18.62 -6.1% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 12/12/2024 |
BWA BorgWarner | $31.01 -1.7% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $41.00 -> $41.00 | N/A | View details for Guggenheim rating of BorgWarner (NYSE:BWA) on 12/12/2024 |
ANAB AnaptysBio | $14.21 -1.0% | 12/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $90.00 -> $36.00 | N/A | View details for Guggenheim rating of AnaptysBio (NASDAQ:ANAB) on 12/12/2024 |
WBD Warner Bros. Discovery | $9.70 -3.6% | 12/12/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $11.00 -> $12.50 | N/A | View details for Guggenheim rating of Warner Bros. Discovery (NASDAQ:WBD) on 12/12/2024 |
ADCT ADC Therapeutics | $1.88 -2.1% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 12/12/2024 |
LOW Lowe's Companies | $247.78 +0.4% | 12/12/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $300.00 -> $300.00 | N/A | View details for Guggenheim rating of Lowe’s Companies (NYSE:LOW) on 12/12/2024 |
M Macy's | $15.89 -0.9% | 12/12/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | N/A | View details for Guggenheim rating of Macy’s (NYSE:M) on 12/12/2024 |
SPRB Spruce Biosciences | $0.37 -2.6% | 12/12/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | N/A | View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 12/12/2024 |
UNFI United Natural Foods | $27.26 -5.5% | 12/12/2024 | Reiterated by | Guggenheim | Analyst J. Heinbockel | Neutral -> Neutral | | N/A | View details for Guggenheim rating of United Natural Foods (NYSE:UNFI) on 12/12/2024 |
BPMC Blueprint Medicines | $87.43 -3.5% | 12/11/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Blueprint Medicines (NASDAQ:BPMC) on 12/11/2024 |
PEG Public Service Enterprise Group | $84.28 -1.2% | 12/11/2024 | Reiterated by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | | N/A | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 12/11/2024 |
QURE uniQure | $13.85 -13.0% | 12/11/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of uniQure (NASDAQ:QURE) on 12/11/2024 |
TRML Tourmaline Bio | $19.70 -1.5% | 12/11/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of Tourmaline Bio (NASDAQ:TRML) on 12/11/2024 |
AZO AutoZone | $3,256.42 -1.4% | 12/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $3,350.00 -> $3,750.00 | N/A | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 12/11/2024 |
GEV GE Vernova | $367.53 +0.3% | 12/11/2024 | Target Lowered by | Guggenheim | Analyst J. Osha | Buy -> Buy | $400.00 -> $380.00 | N/A | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 12/11/2024 |
|
GIII G-III Apparel Group | $31.40 -2.5% | 12/11/2024 | Target Raised by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $36.00 -> $38.00 | N/A | View details for Guggenheim rating of G-III Apparel Group (NASDAQ:GIII) on 12/11/2024 |
PFE Pfizer | $26.73 -0.5% | 12/11/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $35.00 -> $33.00 | N/A | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 12/11/2024 |
VFC VF | $22.73 +5.5% | 12/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $25.00 -> $27.00 | N/A | View details for Guggenheim rating of VF (NYSE:VFC) on 12/11/2024 |
SIRI Sirius XM | $20.83 -3.3% | 12/11/2024 | Reiterated by | Guggenheim | Analyst C. Baker | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 12/11/2024 |
QTTB Q32 Bio | $3.34 +2.1% | 12/11/2024 | Downgraded by | Guggenheim | Analyst Y. Suneja | Buy -> Neutral | | N/A | View details for Guggenheim rating of Q32 Bio (NASDAQ:QTTB) on 12/11/2024 |
TEM Tempus AI | $37.52 +0.1% | 12/9/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $74.00 | N/A | View details for Guggenheim rating of Tempus AI (NASDAQ:TEM) on 12/9/2024 |
TARA Protara Therapeutics | $5.56 -5.9% | 12/6/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for Guggenheim rating of Protara Therapeutics (NASDAQ:TARA) on 12/6/2024 |
CROX Crocs | $110.04 +0.3% | 12/6/2024 | Reiterated by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $155.00 -> $155.00 | N/A | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 12/6/2024 |
DLTR Dollar Tree | $72.90 +1.3% | 12/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $120.00 -> $100.00 | N/A | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 12/6/2024 |
PVH PVH | $99.93 -3.7% | 12/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $105.00 -> $125.00 | N/A | View details for Guggenheim rating of PVH (NYSE:PVH) on 12/6/2024 |
RBRK Rubrik | $63.47 +0.4% | 12/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $52.00 -> $72.00 | N/A | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 12/6/2024 |
LULU Lululemon Athletica | $395.47 +0.6% | 12/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $350.00 -> $415.00 | N/A | View details for Guggenheim rating of Lululemon Athletica (NASDAQ:LULU) on 12/6/2024 |
FLNC Fluence Energy | $16.09 -5.9% | 12/6/2024 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $26.00 -> $26.00 | N/A | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 12/6/2024 |
TSLA Tesla | $394.74 -0.1% | 12/5/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $156.00 -> $175.00 | N/A | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 12/5/2024 |
S SentinelOne | $22.46 -0.2% | 12/5/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $31.00 -> $31.00 | N/A | View details for Guggenheim rating of SentinelOne (NYSE:S) on 12/5/2024 |
APTV Aptiv | $59.43 -2.3% | 12/5/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $73.00 -> $73.00 | N/A | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 12/5/2024 |
ORCL Oracle | $154.36 -5.4% | 12/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $200.00 -> $220.00 | N/A | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 12/5/2024 |
TJX TJX Companies | $120.00 -1.4% | 12/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $135.00 -> $140.00 | N/A | View details for Guggenheim rating of TJX Companies (NYSE:TJX) on 12/5/2024 |
FIVE Five Below | $103.20 +3.7% | 12/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $125.00 -> $140.00 | N/A | View details for Guggenheim rating of Five Below (NASDAQ:FIVE) on 12/5/2024 |
FL Foot Locker | $20.54 -0.1% | 12/5/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $34.00 -> $28.00 | N/A | View details for Guggenheim rating of Foot Locker (NYSE:FL) on 12/5/2024 |
GEV GE Vernova | $367.53 +0.3% | 12/5/2024 | Target Raised by | Guggenheim | Analyst J. Osha | Buy -> Buy | $300.00 -> $400.00 | N/A | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 12/5/2024 |
RH RH | $414.75 +1.6% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $425.00 -> $425.00 | N/A | View details for Guggenheim rating of RH (NYSE:RH) on 12/4/2024 |
CRM Salesforce | $317.83 -2.8% | 12/4/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | | N/A | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 12/4/2024 |
OKTA Okta | $84.37 -1.3% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $130.00 -> $130.00 | N/A | View details for Guggenheim rating of Okta (NASDAQ:OKTA) on 12/4/2024 |
WMG Warner Music Group | $29.34 +0.1% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $44.00 -> $44.00 | N/A | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 12/4/2024 |
BASE Couchbase | $15.80 -1.3% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for Guggenheim rating of Couchbase (NASDAQ:BASE) on 12/4/2024 |
KROS Keros Therapeutics | $14.56 -2.2% | 12/4/2024 | Reiterated by | Guggenheim | Analyst V. Divan | Buy -> Buy | $96.00 -> $102.00 | N/A | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 12/4/2024 |
LYV Live Nation Entertainment | $128.64 -1.3% | 12/4/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $146.00 -> $155.00 | N/A | View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 12/4/2024 |
AZO AutoZone | $3,256.42 -1.4% | 12/4/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | N/A | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 12/4/2024 |
SNAP Snap | $12.47 +3.6% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $12.11 -> $12.11 | N/A | View details for Guggenheim rating of Snap (NYSE:SNAP) on 12/3/2024 |
RVMD Revolution Medicines | $41.78 -5.9% | 12/3/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $82.00 -> $87.00 | N/A | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 12/3/2024 |
ABSI Absci | $2.86 -11.2% | 12/3/2024 | Reiterated by | Guggenheim | Analyst V. Divan | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 12/3/2024 |
APGE Apogee Therapeutics | $41.05 -16.6% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $95.00 -> $110.00 | N/A | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 12/3/2024 |
BNTC Benitec Biopharma | $11.00 -0.5% | 12/3/2024 | Reiterated by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for Guggenheim rating of Benitec Biopharma (NASDAQ:BNTC) on 12/3/2024 |
PRME Prime Medicine | $2.94 -6.7% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for Guggenheim rating of Prime Medicine (NYSE:PRME) on 12/3/2024 |
ZS Zscaler | $189.98 +1.4% | 12/3/2024 | Reiterated by | Guggenheim | - | Neutral | | N/A | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 12/3/2024 |
MRUS Merus | $43.85 +3.8% | 12/3/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $111.00 -> $109.00 | N/A | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 12/3/2024 |
KSS Kohl's | $13.71 +1.6% | 12/2/2024 | Downgraded by | Guggenheim | Analyst R. Drbul | Buy -> Neutral | | N/A | View details for Guggenheim rating of Kohl’s (NYSE:KSS) on 12/2/2024 |
BBY Best Buy | $83.22 -1.2% | 11/29/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $110.00 -> $105.00 | N/A | View details for Guggenheim rating of Best Buy (NYSE:BBY) on 11/29/2024 |
APGE Apogee Therapeutics | $41.05 -16.6% | 11/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $95.00 -> $110.00 | N/A | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 11/27/2024 |
KSS Kohl's | $13.71 +1.6% | 11/27/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $26.00 -> $25.00 | N/A | View details for Guggenheim rating of Kohl’s (NYSE:KSS) on 11/27/2024 |
NJR New Jersey Resources | $45.31 -2.4% | 11/27/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $46.00 -> $49.00 | N/A | View details for Guggenheim rating of New Jersey Resources (NYSE:NJR) on 11/27/2024 |
CPRI Capri | $23.72 +10.3% | 11/26/2024 | Upgraded by | Guggenheim | Analyst R. Drbul | Neutral -> Buy | $30.00 | N/A | View details for Guggenheim rating of Capri (NYSE:CPRI) on 11/26/2024 |
KR Kroger | $59.24 +0.6% | 11/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $61.00 -> $63.00 | N/A | View details for Guggenheim rating of Kroger (NYSE:KR) on 11/25/2024 |
NXT Nextracker | $41.10 -3.4% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $55.00 -> $55.00 | N/A | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 11/22/2024 |
ROST Ross Stores | $151.74 -1.9% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $180.00 -> $180.00 | N/A | View details for Guggenheim rating of Ross Stores (NASDAQ:ROST) on 11/22/2024 |
WMG Warner Music Group | $29.34 +0.1% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $44.00 -> $44.00 | N/A | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 11/22/2024 |
CPK Chesapeake Utilities | $116.45 -2.1% | 11/22/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $118.00 -> $129.00 | N/A | View details for Guggenheim rating of Chesapeake Utilities (NYSE:CPK) on 11/22/2024 |
ESTC Elastic | $97.33 -0.7% | 11/22/2024 | Target Raised by | Guggenheim | Analyst H. Ma | Buy -> Buy | $100.00 -> $120.00 | N/A | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 11/22/2024 |
GAP GAP | $24.10 +1.2% | 11/22/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $35.00 -> $35.00 | N/A | View details for Guggenheim rating of GAP (NYSE:GAP) on 11/22/2024 |
|
SHLS Shoals Technologies Group | $5.89 -1.8% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $8.00 -> $7.00 | N/A | View details for Guggenheim rating of Shoals Technologies Group (NASDAQ:SHLS) on 11/21/2024 |
TGT Target | $141.78 +2.6% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $180.00 -> $145.00 | N/A | View details for Guggenheim rating of Target (NYSE:TGT) on 11/21/2024 |
AN AutoNation | $170.72 -1.5% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $190.00 -> $189.00 | N/A | View details for Guggenheim rating of AutoNation (NYSE:AN) on 11/21/2024 |
APTV Aptiv | $59.43 -2.3% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $87.00 -> $73.00 | N/A | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 11/21/2024 |
GNTX Gentex | $26.86 -1.2% | 11/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $35.00 -> $34.00 | N/A | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 11/21/2024 |
GPI Group 1 Automotive | $421.09 +0.1% | 11/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $420.00 -> $442.00 | N/A | View details for Guggenheim rating of Group 1 Automotive (NYSE:GPI) on 11/21/2024 |
LAD Lithia Motors | $342.32 -1.9% | 11/21/2024 | Target Raised by | Guggenheim | Analyst R. Jewsikow | Buy -> Buy | $380.00 -> $418.00 | N/A | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 11/21/2024 |
WMT Walmart | $93.03 +1.3% | 11/20/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $90.00 -> $100.00 | N/A | View details for Guggenheim rating of Walmart (NYSE:WMT) on 11/20/2024 |
JACK Jack in the Box | $37.20 -2.4% | 11/20/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $95.00 -> $60.00 | N/A | View details for Guggenheim rating of Jack in the Box (NASDAQ:JACK) on 11/20/2024 |
SEDG SolarEdge Technologies | $14.71 -1.9% | 11/20/2024 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | | N/A | View details for Guggenheim rating of SolarEdge Technologies (NASDAQ:SEDG) on 11/20/2024 |
RBRK Rubrik | $63.47 +0.4% | 11/19/2024 | Target Raised by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $48.00 -> $52.00 | N/A | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 11/19/2024 |
SBGI Sinclair | $15.65 -5.4% | 11/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $18.00 -> $19.00 | N/A | View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 11/19/2024 |
FUN Cedar Fair | $46.30 -1.5% | 11/19/2024 | Target Raised by | Guggenheim | Analyst C. Baker | Buy -> Buy | $52.00 -> $55.00 | N/A | View details for Guggenheim rating of Cedar Fair (NYSE:FUN) on 11/19/2024 |
IHRT iHeartMedia | $1.88 -5.5% | 11/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $3.00 -> $5.00 | N/A | View details for Guggenheim rating of iHeartMedia (NASDAQ:IHRT) on 11/19/2024 |
ADAP Adaptimmune Therapeutics | $0.62 +0.0% | 11/15/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $4.00 -> $3.00 | N/A | View details for Guggenheim rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 11/15/2024 |
CNTA Centessa Pharmaceuticals | $15.64 -2.9% | 11/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $24.00 -> $28.00 | N/A | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 11/15/2024 |
DIS Walt Disney | $108.68 -1.0% | 11/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $110.00 -> $130.00 | N/A | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 11/15/2024 |
TPR Tapestry | $67.25 -1.9% | 11/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $60.00 -> $70.00 | N/A | View details for Guggenheim rating of Tapestry (NYSE:TPR) on 11/15/2024 |
ZNTL Zentalis Pharmaceuticals | $2.75 -1.1% | 11/15/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $12.00 -> $8.00 | N/A | View details for Guggenheim rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 11/15/2024 |
GTN Gray Television | $3.38 -4.5% | 11/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $10.00 -> $8.00 | N/A | View details for Guggenheim rating of Gray Television (NYSE:GTN) on 11/12/2024 |
LYV Live Nation Entertainment | $128.64 -1.3% | 11/12/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $130.00 -> $146.00 | N/A | View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 11/12/2024 |
MSGE Madison Square Garden Entertainment | $34.31 +0.0% | 11/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $49.00 -> $48.00 | N/A | View details for Guggenheim rating of Madison Square Garden Entertainment (NYSE:MSGE) on 11/12/2024 |
NWSA News | $26.98 -1.8% | 11/12/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $36.00 -> $40.00 | N/A | View details for Guggenheim rating of News (NASDAQ:NWSA) on 11/12/2024 |
PRKS United Parks & Resorts | $55.28 -3.5% | 11/12/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $72.00 -> $70.00 | N/A | View details for Guggenheim rating of United Parks & Resorts (NYSE:PRKS) on 11/12/2024 |
SMAR Smartsheet | $56.37 +0.3% | 11/11/2024 | Downgraded by | Guggenheim | Analyst J. Difucci | Buy -> Neutral | | N/A | View details for Guggenheim rating of Smartsheet (NYSE:SMAR) on 11/11/2024 |
CDTX Cidara Therapeutics | $24.00 -3.5% | 11/8/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $33.00 | N/A | View details for Guggenheim rating of Cidara Therapeutics (NASDAQ:CDTX) on 11/8/2024 |
SIRI Sirius XM | $20.83 -3.3% | 11/6/2024 | Downgraded by | Guggenheim | Analyst C. Baker | Strong-Buy -> Hold | | N/A | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 11/6/2024 |
FOLD Amicus Therapeutics | $9.02 -4.7% | 11/7/2024 | Target Raised by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | $13.00 -> $15.00 | N/A | View details for Guggenheim rating of Amicus Therapeutics (NASDAQ:FOLD) on 11/7/2024 |
PFGC Performance Food Group | $84.60 -1.4% | 11/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $90.00 -> $95.00 | N/A | View details for Guggenheim rating of Performance Food Group (NYSE:PFGC) on 11/7/2024 |
SRPT Sarepta Therapeutics | $124.79 -1.2% | 11/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $148.00 -> $150.00 | N/A | View details for Guggenheim rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/7/2024 |
TNGX Tango Therapeutics | $2.92 -9.6% | 11/7/2024 | Target Lowered by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $18.00 -> $8.00 | N/A | View details for Guggenheim rating of Tango Therapeutics (NASDAQ:TNGX) on 11/7/2024 |
RUN Sunrun | $10.04 -6.6% | 11/7/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | N/A | View details for Guggenheim rating of Sunrun (NASDAQ:RUN) on 11/7/2024 |
NOVA Sunnova Energy International | $3.43 -12.5% | 11/7/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | N/A | View details for Guggenheim rating of Sunnova Energy International (NYSE:NOVA) on 11/7/2024 |
ARRY Array Technologies | $6.43 -1.5% | 11/7/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Neutral | | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 11/7/2024 |
JNJ Johnson & Johnson | $142.07 -0.1% | 11/6/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $156.00 -> $162.00 | N/A | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 11/6/2024 |
MRK Merck & Co., Inc. | $99.34 -0.5% | 11/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $137.00 -> $130.00 | N/A | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 11/6/2024 |
RIVN Rivian Automotive | $13.85 -2.5% | 11/6/2024 | Target Lowered by | Guggenheim | Analyst R. Jewsikow | Buy -> Buy | $21.00 -> $18.00 | N/A | View details for Guggenheim rating of Rivian Automotive (NASDAQ:RIVN) on 11/6/2024 |
ABBV AbbVie | $175.18 -1.9% | 11/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $212.00 -> $221.00 | N/A | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 11/6/2024 |
DAVA Endava | $31.25 +0.0% | 11/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $45.00 -> $40.00 | N/A | View details for Guggenheim rating of Endava (NYSE:DAVA) on 11/6/2024 |
ITRI Itron | $103.61 -3.1% | 11/6/2024 | Target Raised by | Guggenheim | Analyst J. Osha | Buy -> Buy | $128.00 -> $135.00 | N/A | View details for Guggenheim rating of Itron (NASDAQ:ITRI) on 11/6/2024 |
FOXA FOX | $48.19 -1.6% | 11/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $45.00 -> $50.00 | Medium | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 11/5/2024 |
KTB Kontoor Brands | $86.26 -2.0% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $80.00 -> $100.00 | Medium | View details for Guggenheim rating of Kontoor Brands (NYSE:KTB) on 11/1/2024 |
ETR Entergy | $76.18 -0.5% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $72.50 -> $82.50 | Low | View details for Guggenheim rating of Entergy (NYSE:ETR) on 11/1/2024 |
KYMR Kymera Therapeutics | $38.17 -5.8% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $45.00 -> $52.00 | Medium | View details for Guggenheim rating of Kymera Therapeutics (NASDAQ:KYMR) on 11/1/2024 |
ARGX argenx | $656.26 +1.1% | 11/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $585.00 -> $665.00 | High | View details for Guggenheim rating of argenx (NASDAQ:ARGX) on 11/1/2024 |
GSK GSK | $33.08 -2.0% | 10/31/2024 | Downgraded by | Guggenheim | Analyst S. Fernandez | Buy -> Neutral | | Medium | View details for Guggenheim rating of GSK (NYSE:GSK) on 10/31/2024 |
CROX Crocs | $110.04 +0.3% | 10/30/2024 | Target Lowered by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $182.00 -> $155.00 | Low | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 10/30/2024 |
EXEL Exelixis | $36.02 +4.4% | 10/30/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $32.00 -> $33.00 | Medium | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 10/30/2024 |
FSLR First Solar | $189.24 -1.0% | 10/30/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $368.00 -> $335.00 | Medium | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 10/30/2024 |
NFLX Netflix | $837.69 -4.3% | 10/29/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $810.00 -> $825.00 | N/A | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/29/2024 |
|
FUN Cedar Fair | $46.30 -1.5% | 10/29/2024 | Initiated by | Guggenheim | Analyst C. Baker | Buy | $52.00 | Medium | View details for Guggenheim rating of Cedar Fair (NYSE:FUN) on 10/29/2024 |
GNLX Genelux | $2.58 +1.2% | 10/29/2024 | Initiated by | Guggenheim | Analyst K. Goodwin | Buy | $8.00 | Low | View details for Guggenheim rating of Genelux (NASDAQ:GNLX) on 10/29/2024 |
RL Ralph Lauren | $236.78 -2.6% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $200.00 -> $225.00 | Low | View details for Guggenheim rating of Ralph Lauren (NYSE:RL) on 10/28/2024 |
PVH PVH | $99.93 -3.7% | 10/28/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $120.00 -> $105.00 | Medium | View details for Guggenheim rating of PVH (NYSE:PVH) on 10/28/2024 |
WMT Walmart | $93.03 +1.3% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $81.00 -> $90.00 | Low | View details for Guggenheim rating of Walmart (NYSE:WMT) on 10/28/2024 |
VERA Vera Therapeutics | $37.02 -12.3% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $56.00 -> $64.00 | High | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 10/28/2024 |
RVMD Revolution Medicines | $41.78 -5.9% | 10/28/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $72.00 -> $82.00 | Medium | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 10/28/2024 |
NEP NextEra Energy Partners | $18.11 -0.8% | 10/28/2024 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | $37.00 -> $22.00 | Medium | View details for Guggenheim rating of NextEra Energy Partners (NYSE:NEP) on 10/28/2024 |
SYRE Spyre Therapeutics | $22.46 -6.5% | 10/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $50.00 -> $65.00 | Medium | View details for Guggenheim rating of Spyre Therapeutics (NASDAQ:SYRE) on 10/25/2024 |
LAD Lithia Motors | $342.32 -1.9% | 10/24/2024 | Target Raised by | Guggenheim | Analyst R. Jewsikow | Buy -> Buy | $350.00 -> $380.00 | Low | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 10/24/2024 |
NEE NextEra Energy | $67.39 -4.6% | 10/24/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $90.00 -> $92.00 | Low | View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 10/24/2024 |
TSLA Tesla | $394.74 -0.1% | 10/24/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $153.00 -> $156.00 | Medium | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 10/24/2024 |
MCD McDonald's | $282.22 -1.6% | 10/23/2024 | Downgraded by | Guggenheim | Analyst G. Francfort | Buy -> Neutral | $290.00 -> $285.00 | High | View details for Guggenheim rating of McDonald’s (NYSE:MCD) on 10/23/2024 |
ENPH Enphase Energy | $66.74 -4.2% | 10/23/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Neutral -> Sell | $73.00 | Low | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 10/23/2024 |
ANAB AnaptysBio | $14.21 -1.0% | 10/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $75.00 -> $90.00 | Low | View details for Guggenheim rating of AnaptysBio (NASDAQ:ANAB) on 10/21/2024 |
RYTM Rhythm Pharmaceuticals | $56.17 -2.9% | 10/21/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $70.00 | High | View details for Guggenheim rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 10/21/2024 |
INFA Informatica | $25.05 -2.2% | 10/18/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | | Low | View details for Guggenheim rating of Informatica (NYSE:INFA) on 10/18/2024 |
PSTG Pure Storage | $64.88 +1.0% | 10/17/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $72.00 -> $93.00 | High | View details for Guggenheim rating of Pure Storage (NYSE:PSTG) on 10/17/2024 |
GRAL Grail | $17.73 +0.4% | 10/17/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Neutral | | Medium | View details for Guggenheim rating of Grail (NASDAQ:GRAL) on 10/17/2024 |
SEDG SolarEdge Technologies | $14.71 -1.9% | 10/17/2024 | Downgraded by | Guggenheim | Analyst J. Osha | Neutral -> Sell | $10.00 | Low | View details for Guggenheim rating of SolarEdge Technologies (NASDAQ:SEDG) on 10/17/2024 |
ENPH Enphase Energy | $66.74 -4.2% | 10/17/2024 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | | Medium | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 10/17/2024 |
CVLT Commvault Systems | $153.98 -2.4% | 10/15/2024 | Downgraded by | Guggenheim | Analyst H. Ma | Buy -> Neutral | | High | View details for Guggenheim rating of Commvault Systems (NASDAQ:CVLT) on 10/15/2024 |
TENX Tenax Therapeutics | $6.24 -3.7% | 10/14/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $16.00 | High | View details for Guggenheim rating of Tenax Therapeutics (NASDAQ:TENX) on 10/14/2024 |
NFLX Netflix | $837.69 -4.3% | 10/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $735.00 -> $810.00 | Medium | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/11/2024 |
VCYT Veracyte | $41.54 -5.1% | 10/10/2024 | Initiated by | Guggenheim | Analyst S. Nambi | Buy | $40.00 | High | View details for Guggenheim rating of Veracyte (NASDAQ:VCYT) on 10/10/2024 |
TVTX Travere Therapeutics | $18.09 -4.8% | 10/9/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $23.00 -> $41.00 | High | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 10/9/2024 |
IONS Ionis Pharmaceuticals | $33.46 -1.9% | 10/9/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $70.00 -> $65.00 | Low | View details for Guggenheim rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 10/9/2024 |
GIII G-III Apparel Group | $31.40 -2.5% | 10/9/2024 | Initiated by | Guggenheim | Analyst R. Drbul | Buy | $36.00 | High | View details for Guggenheim rating of G-III Apparel Group (NASDAQ:GIII) on 10/9/2024 |
DECK Deckers Outdoor | $207.60 +0.0% | 10/9/2024 | Initiated by | Guggenheim | Analyst R. Drbul | Neutral | | Low | View details for Guggenheim rating of Deckers Outdoor (NYSE:DECK) on 10/9/2024 |
CROX Crocs | $110.04 +0.3% | 10/9/2024 | Initiated by | Guggenheim | Analyst R. Drbul | Buy | $182.00 | Low | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 10/9/2024 |
VST Vistra | $167.08 +3.9% | 10/8/2024 | Target Raised by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $133.00 -> $177.00 | Low | View details for Guggenheim rating of Vistra (NYSE:VST) on 10/8/2024 |
TLN Talen Energy | $221.80 +2.9% | 10/8/2024 | Target Raised by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $219.00 -> $246.00 | N/A | View details for Guggenheim rating of Talen Energy (NASDAQ:TLN) on 10/8/2024 |
NRG NRG Energy | $99.35 +0.8% | 10/8/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $77.00 -> $118.00 | Medium | View details for Guggenheim rating of NRG Energy (NYSE:NRG) on 10/8/2024 |
MBX MBX Biosciences | $13.69 -5.7% | 10/8/2024 | Initiated by | Guggenheim | Analyst S. Fernandez | Buy | $44.00 | High | View details for Guggenheim rating of MBX Biosciences (NYSE:MBX) on 10/8/2024 |
META Meta Platforms | $615.86 +0.8% | 10/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $600.00 -> $665.00 | N/A | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 10/7/2024 |
SN SharkNinja | $107.89 +5.5% | 10/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $100.00 -> $120.00 | Low | View details for Guggenheim rating of SharkNinja (NYSE:SN) on 10/7/2024 |
IMCR Immunocore | $30.40 +0.6% | 10/7/2024 | Downgraded by | Guggenheim | Analyst M. Schmidt | Buy -> Neutral | | High | View details for Guggenheim rating of Immunocore (NASDAQ:IMCR) on 10/7/2024 |
ZVRA Zevra Therapeutics | $8.11 -4.9% | 10/7/2024 | Initiated by | Guggenheim | Analyst E. Hickman | Buy | $20.00 | High | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 10/7/2024 |
NXST Nexstar Media Group | $150.43 -4.5% | 10/4/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $200.00 -> $198.00 | Low | View details for Guggenheim rating of Nexstar Media Group (NASDAQ:NXST) on 10/4/2024 |
HD Home Depot | $390.12 +0.8% | 10/4/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $390.00 -> $450.00 | Low | View details for Guggenheim rating of Home Depot (NYSE:HD) on 10/4/2024 |
ARRY Array Technologies | $6.43 -1.5% | 10/4/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $14.00 -> $12.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 10/4/2024 |
ENPH Enphase Energy | $66.74 -4.2% | 10/4/2024 | Target Lowered by | Guggenheim | - | Sell -> Sell | $93.00 -> $90.00 | Medium | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 10/4/2024 |
FWRG First Watch Restaurant Group | $19.12 -1.3% | 10/4/2024 | Target Lowered by | Guggenheim | Analyst G. Francfort | Buy -> Buy | $24.00 -> $20.00 | Medium | View details for Guggenheim rating of First Watch Restaurant Group (NASDAQ:FWRG) on 10/4/2024 |
SO Southern | $81.25 -2.1% | 10/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $93.00 -> $97.00 | Low | View details for Guggenheim rating of Southern (NYSE:SO) on 10/2/2024 |
NKE NIKE | $71.31 +0.0% | 10/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $115.00 -> $110.00 | Low | View details for Guggenheim rating of NIKE (NYSE:NKE) on 10/2/2024 |
ABSI Absci | $2.86 -11.2% | 10/2/2024 | Initiated by | Guggenheim | Analyst V. Divan | Buy | $10.00 | High | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 10/2/2024 |
BTSG BrightSpring Health Services | $17.17 -0.9% | 10/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $15.00 -> $18.00 | Medium | View details for Guggenheim rating of BrightSpring Health Services (NASDAQ:BTSG) on 10/1/2024 |
IGMS IGM Biosciences | $2.09 -66.3% | 10/1/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $25.00 -> $20.00 | Medium | View details for Guggenheim rating of IGM Biosciences (NASDAQ:IGMS) on 10/1/2024 |
MRUS Merus | $43.85 +3.8% | 10/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $93.00 -> $111.00 | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 10/1/2024 |
VEEV Veeva Systems | $218.08 +0.4% | 10/1/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $233.00 -> $249.00 | Low | View details for Guggenheim rating of Veeva Systems (NYSE:VEEV) on 10/1/2024 |
|
TTEC TTEC | $4.00 -2.7% | 10/1/2024 | Upgraded by | Guggenheim | Analyst J. Lee | Sell -> Neutral | | Medium | View details for Guggenheim rating of TTEC (NASDAQ:TTEC) on 10/1/2024 |
TKO TKO Group | $140.30 -1.4% | 9/30/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $135.00 -> $140.00 | Medium | View details for Guggenheim rating of TKO Group (NYSE:TKO) on 9/30/2024 |
ACET Adicet Bio | $0.92 -4.2% | 9/30/2024 | Initiated by | Guggenheim | Analyst M. Schmidt | Hold -> Buy | $7.00 | High | View details for Guggenheim rating of Adicet Bio (NASDAQ:ACET) on 9/30/2024 |
VSTM Verastem | $5.73 -2.9% | 9/30/2024 | Initiated by | Guggenheim | Analyst M. Schmidt | Buy | $13.00 | High | View details for Guggenheim rating of Verastem (NASDAQ:VSTM) on 9/30/2024 |
ACN Accenture | $349.93 -2.2% | 9/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $380.00 -> $395.00 | Medium | View details for Guggenheim rating of Accenture (NYSE:ACN) on 9/27/2024 |
DT Dynatrace | $50.64 -3.0% | 9/27/2024 | Target Raised by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $55.00 -> $64.00 | Low | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 9/27/2024 |
TVTX Travere Therapeutics | $18.09 -4.8% | 9/27/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $25.00 -> $23.00 | High | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 9/27/2024 |
W Wayfair | $44.08 -2.8% | 9/26/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $70.00 -> $70.00 | Low | View details for Guggenheim rating of Wayfair (NYSE:W) on 9/26/2024 |
DPZ Domino's Pizza | $402.33 -2.5% | 9/26/2024 | Target Lowered by | Guggenheim | - | Neutral -> Neutral | $485.00 -> $460.00 | Low | View details for Guggenheim rating of Domino’s Pizza (NASDAQ:DPZ) on 9/26/2024 |
ARGX argenx | $656.26 +1.1% | 9/26/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $585.00 -> $585.00 | High | View details for Guggenheim rating of argenx (NASDAQ:ARGX) on 9/26/2024 |
TXRH Texas Roadhouse | $178.12 -2.2% | 9/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $190.00 -> $195.00 | Low | View details for Guggenheim rating of Texas Roadhouse (NASDAQ:TXRH) on 9/25/2024 |
PRGS Progress Software | $62.20 -1.8% | 9/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $64.00 -> $70.00 | High | View details for Guggenheim rating of Progress Software (NASDAQ:PRGS) on 9/25/2024 |
PARA Paramount Global | $10.48 -1.5% | 9/25/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $19.00 -> $14.00 | Low | View details for Guggenheim rating of Paramount Global (NASDAQ:PARA) on 9/25/2024 |
AZO AutoZone | $3,256.42 -1.4% | 9/25/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $3,225.00 -> $3,350.00 | Low | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 9/25/2024 |
FOXA FOX | $48.19 -1.6% | 9/24/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $44.00 -> $45.00 | Low | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 9/24/2024 |
GEV GE Vernova | $367.53 +0.3% | 9/24/2024 | Initiated by | Guggenheim | Analyst J. Osha | Buy | $300.00 | Low | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 9/24/2024 |
KROS Keros Therapeutics | $14.56 -2.2% | 9/23/2024 | Initiated by | Guggenheim | Analyst V. Divan | Buy | $96.00 | High | View details for Guggenheim rating of Keros Therapeutics (NASDAQ:KROS) on 9/23/2024 |
SPHR Sphere Entertainment | $41.87 +1.2% | 9/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $58.00 -> $63.00 | Medium | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 9/19/2024 |
SIRI Sirius XM | $20.83 -3.3% | 9/18/2024 | Upgraded by | Guggenheim | Analyst C. Baker | Neutral -> Buy | $30.00 | Medium | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 9/18/2024 |
NUVL Nuvalent | $76.61 -2.1% | 9/16/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $99.00 -> $105.00 | High | View details for Guggenheim rating of Nuvalent (NASDAQ:NUVL) on 9/16/2024 |
INCY Incyte | $70.54 -3.5% | 9/16/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $86.00 -> $92.00 | Medium | View details for Guggenheim rating of Incyte (NASDAQ:INCY) on 9/16/2024 |
DAVA Endava | $31.25 +0.0% | 9/16/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $55.00 -> $45.00 | Medium | View details for Guggenheim rating of Endava (NYSE:DAVA) on 9/16/2024 |
TSLA Tesla | $394.74 -0.1% | 9/13/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $134.00 -> $153.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 9/13/2024 |
ORCL Oracle | $154.36 -5.4% | 9/13/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $185.00 -> $200.00 | Low | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 9/13/2024 |
BNTC Benitec Biopharma | $11.00 -0.5% | 9/12/2024 | Initiated by | Guggenheim | Analyst D. Chattopadhyay | Buy | $17.00 | High | View details for Guggenheim rating of Benitec Biopharma (NASDAQ:BNTC) on 9/12/2024 |
CNTA Centessa Pharmaceuticals | $15.64 -2.9% | 9/11/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $20.00 -> $24.00 | High | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 9/11/2024 |
ESTC Elastic | $97.33 -0.7% | 9/11/2024 | Initiated by | Guggenheim | Analyst H. Ma | Buy | $100.00 | Medium | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 9/11/2024 |
PROK ProKidney | $1.62 -2.4% | 9/10/2024 | Initiated by | Guggenheim | Analyst V. Divan | Buy | $6.00 | Medium | View details for Guggenheim rating of ProKidney (NASDAQ:PROK) on 9/10/2024 |
QSR Restaurant Brands International | $60.94 -2.6% | 9/9/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $73.00 -> $74.00 | Low | View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 9/9/2024 |
TVTX Travere Therapeutics | $18.09 -4.8% | 9/9/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $25.00 | High | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 9/9/2024 |
DLTR Dollar Tree | $72.90 +1.3% | 9/6/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $150.00 -> $120.00 | Low | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 9/6/2024 |
SMAR Smartsheet | $56.37 +0.3% | 9/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $60.00 -> $62.00 | Low | View details for Guggenheim rating of Smartsheet (NYSE:SMAR) on 9/6/2024 |
OS Onestream | $27.14 +3.0% | 9/4/2024 | Target Raised by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $34.00 -> $35.00 | Low | View details for Guggenheim rating of Onestream (NASDAQ:OS) on 9/4/2024 |
TLN Talen Energy | $221.80 +2.9% | 9/4/2024 | Initiated by | Guggenheim | Analyst S. Pourreza | Buy | $169.00 | N/A | View details for Guggenheim rating of Talen Energy (NASDAQ:TLN) on 9/4/2024 |
LULU Lululemon Athletica | $395.47 +0.6% | 8/30/2024 | Target Lowered by | Guggenheim | - | Buy | $525.00 -> $350.00 | Low | View details for Guggenheim rating of Lululemon Athletica (NASDAQ:LULU) on 8/30/2024 |
NBTX Nanobiotix | $2.83 -1.0% | 8/28/2024 | Initiated by | Guggenheim | Analyst M. Schmidt | Buy | $12.00 | Low | View details for Guggenheim rating of Nanobiotix (NASDAQ:NBTX) on 8/28/2024 |
RZLT Rezolute | $4.90 -6.0% | 8/27/2024 | Initiated by | Guggenheim | Analyst D. Chattopadhyay | Buy | $11.00 | Low | View details for Guggenheim rating of Rezolute (NASDAQ:RZLT) on 8/27/2024 |
ROKU Roku | $79.19 -4.6% | 8/23/2024 | Upgraded by | Guggenheim | Analyst M. Morris | Neutral -> Buy | $75.00 | Low | View details for Guggenheim rating of Roku (NASDAQ:ROKU) on 8/23/2024 |
URGN UroGen Pharma | $10.24 -7.2% | 8/22/2024 | Initiated by | Guggenheim | Analyst K. Goodwin | Buy | $40.00 | Low | View details for Guggenheim rating of UroGen Pharma (NASDAQ:URGN) on 8/22/2024 |
OS Onestream | $27.14 +3.0% | 8/19/2024 | Initiated by | Guggenheim | Analyst J. Difucci | Buy | $34.00 | Low | View details for Guggenheim rating of Onestream (NASDAQ:OS) on 8/19/2024 |
WMT Walmart | $93.03 +1.3% | 8/16/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $75.00 -> $81.00 | Low | View details for Guggenheim rating of Walmart (NYSE:WMT) on 8/16/2024 |
ARRY Array Technologies | $6.43 -1.5% | 8/16/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $18.00 -> $14.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 8/16/2024 |
LLY Eli Lilly and Company | $799.39 +1.5% | 8/16/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $884.00 -> $1,030.00 | Low | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 8/16/2024 |
NXT Nextracker | $41.10 -3.4% | 8/16/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $60.00 -> $55.00 | Low | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 8/16/2024 |
DYN Dyne Therapeutics | $15.87 -31.1% | 8/15/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $45.00 -> $50.00 | Low | View details for Guggenheim rating of Dyne Therapeutics (NASDAQ:DYN) on 8/15/2024 |
GTN Gray Television | $3.38 -4.5% | 8/14/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $12.00 -> $10.00 | Low | View details for Guggenheim rating of Gray Television (NYSE:GTN) on 8/14/2024 |
PRAX Praxis Precision Medicines | $63.15 -14.3% | 8/14/2024 | Target Raised by | Guggenheim | Analyst Y. Suneja | Buy -> Buy | $155.00 -> $170.00 | Low | View details for Guggenheim rating of Praxis Precision Medicines (NASDAQ:PRAX) on 8/14/2024 |
VIGL Vigil Neuroscience | $1.79 -2.7% | 8/14/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $17.00 -> $16.00 | Low | View details for Guggenheim rating of Vigil Neuroscience (NASDAQ:VIGL) on 8/14/2024 |
RVNC Revance Therapeutics | $3.25 -4.1% | 8/12/2024 | Reiterated by | Guggenheim | Analyst S. Fernandez | Buy -> Neutral | | Low | View details for Guggenheim rating of Revance Therapeutics (NASDAQ:RVNC) on 8/12/2024 |
LAD Lithia Motors | $342.32 -1.9% | 8/9/2024 | Upgraded by | Guggenheim | Analyst R. Jewsikow | Neutral -> Buy | $338.00 | Low | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 8/9/2024 |
FLNC Fluence Energy | $16.09 -5.9% | 8/9/2024 | Upgraded by | Guggenheim | Analyst J. Osha | Neutral -> Buy | $26.00 | Low | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 8/9/2024 |
BROS Dutch Bros | $57.42 +2.2% | 8/8/2024 | Upgraded by | Guggenheim | Analyst G. Francfort | Neutral -> Buy | | Low | View details for Guggenheim rating of Dutch Bros (NYSE:BROS) on 8/8/2024 |
LLY Eli Lilly and Company | $799.39 +1.5% | 8/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $855.00 -> $884.00 | Low | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 8/5/2024 |
FND Floor & Decor | $95.03 -1.2% | 8/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $130.00 -> $115.00 | Low | View details for Guggenheim rating of Floor & Decor (NYSE:FND) on 8/2/2024 |
ETR Entergy | $76.18 -0.5% | 8/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $59.00 -> $64.00 | Low | View details for Guggenheim rating of Entergy (NYSE:ETR) on 8/2/2024 |
ED Consolidated Edison | $88.19 -0.9% | 8/2/2024 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $88.00 -> $91.00 | Low | View details for Guggenheim rating of Consolidated Edison (NYSE:ED) on 8/2/2024 |
BPMC Blueprint Medicines | $87.43 -3.5% | 8/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $130.00 -> $138.00 | Low | View details for Guggenheim rating of Blueprint Medicines (NASDAQ:BPMC) on 8/2/2024 |
REGN Regeneron Pharmaceuticals | $696.88 -5.0% | 8/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $1,180.00 -> $1,300.00 | Low | View details for Guggenheim rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 8/2/2024 |
NET Cloudflare | $112.91 -2.4% | 8/2/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $50.00 -> $57.00 | Low | View details for Guggenheim rating of Cloudflare (NYSE:NET) on 8/2/2024 |
NBIX Neurocrine Biosciences | $140.90 +1.6% | 8/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $170.00 -> $180.00 | Low | View details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 8/2/2024 |